glp 1 receptor agonists names list of medications GLP-1/GIP and Diabetic Retinopathy: What ODs Should Glucagon-like peptide-1 receptor agonists (GLP-1RAs)
Description
While several cardiovascular and renal outcome studies have been reported since publication of the 2018 ACC decision pathway, the document remains useful in terms of providing patient-specific considerations when determining which class of medications to select in a person with T2D
Yet, there are still many unanswered questions surrounding their use and long-term effects
Atherosclerosis (2015) 240(1):2509
Detka J, Slusarczyk J, Kurek A, Kucharczyk M, Adamus T, et al
GIP activation may also improve lipid processing and growth of white adipose tissue, resulting in complementary processes
